List of Papers Browse by Subject Areas Author List
Abstract
Epilepsy is a chronic neurological disorder requiring multi-faceted management, including seizure detection, syndrome diagnosis, prognostication, antiseizure medication recommendation, epileptogenic zone localization, and surgical outcome prediction. Although numerous deep learning approaches have been developed for individual tasks, these models are typically siloed and modality-specific (e.g., EEG for seizure detection, MRI for localization), failing to reflect the multidisciplinary nature of real-world epilepsy care, where epileptologists, neuroradiologists, neurosurgeons, neuropsychologists and neuropsychiatrists jointly interpret heterogeneous evidence to guide decisions. In this work, we propose a clinical guideline-grounded hybrid multi-agent framework for holistic epilepsy management. Heterogeneous patient data is processed through modality-specific discriminative and generative models, where textual interpretations from generative agents are combined with structured predictions from discriminative models as auxiliary guidance. This aggregated evidence is passed to a central orchestrating agent grounded in international epilepsy guidelines, which evaluates multi-modal findings within structured clinical pathways and performs iterative cross-agent coordination for evidence-informed decision-making. We evaluate our framework across two datasets spanning six epilepsy management tasks and also introduce a publicly available multi-modal, multi-task epilepsy benchmark. Results demonstrate that integrating discriminative evidence with guideline-grounded generative coordination yields more reliable and comprehensive decisions compared to conventional LLM-based and task-specific baselines. Our dataset and code is available at https://github.com/khoapham154/epi_guide.git.
Links to Paper and Supplementary Materials
Main Paper (Open Access Version): https://papers.miccai.org/miccai-2026/paper/2852_paper.pdf
SharedIt Link: Not yet available
SpringerLink (DOI): Not yet available
Supplementary Material: Not Submitted
Link to the Code Repository
https://github.com/khoapham154/epi_guide
Link to the Dataset(s)
N/A
BibTex
@InProceedings{PhaDuy_AClinical_MICCAI2026,
author = { Pham, Duy Khoa AND Giritharan, Dinesh AND Camargo de Oliveira, Guilherme AND Vo, Bao Quoc AND Verspoor, Karin AND Law, Meng AND Kwan, Patrick AND Ge, Zongyuan AND Mehta, Deval},
title = { { A Clinical Guideline-Grounded Hybrid Agentic Framework for Holistic Epilepsy Management } },
booktitle = {Medical Image Computing and Computer Assisted Intervention -- MICCAI 2026},
year = {2026},
publisher = {Springer Nature Switzerland},
volume = {LNCS 16895},
month = {September},
page = {pending}
}
Reviews
Review #1
- Please describe the contribution of the paper
This paper introduces EPI-GUIDE, the first clinical guideline-based hybrid multi-agent framework for the holistic epilepsy management. To address the limitations of existing epilepsy AI models—specifically their unimodal and single-task constraints—as well as the hallucination issues inherent in purely generative large models, this framework couples discriminative models (which provide structured predictions) with generative agents (which produce textual explanations). These elements are integrated by a guideline-driven orchestrating agent that synthesizes multimodal evidence to generate the final output. Furthermore, the authors constructed and evaluated a multimodal, multi-task epilepsy dataset involving 306 patients, with plans for its open-source release.
- Please list the major strengths of the paper: you should highlight a novel formulation, an original way to use data, demonstration of clinical feasibility, a novel application, a particularly strong evaluation, or anything else that is a strong aspect of this work. Please provide details, for instance, if a method is novel, explain what aspect is novel and why this is interesting.
1、Existing medical large language models often suffer from weak numerical reasoning and a high propensity for hallucinations. This paper mitigates these issues by introducing discriminative models to provide probabilistic metrics and predictive results, which are then converted into textual evidence for the LLM. This design retains the high precision of deep learning in image/signal processing while leveraging the LLM’s logical reasoning, closely mimicking the multidisciplinary team consultation paradigm in real-world clinical practice. 2、Before making a final decision, the system cross-references multimodal evidence with standardized clinical pathways retrieved via RAG. If contradictions arise, the system triggers a “FOLLOW-UP” mechanism for multi-turn dialogue to resolve conflicts. This fully transparent reasoning process not only enhances performance but also significantly bolsters clinician trust in the model’s outputs.
- Please list the major weaknesses of the paper. Please provide details: for instance, if you state that a formulation, way of using data, demonstration of clinical feasibility, or application is not novel, then you must provide specific references to prior work.
1、Limited depth in multimodal representation fusion. The current framework utilizes a typical “Late Fusion” approach, where each modality independently generates text or predictive probabilities before being concatenated and fed to the central orchestrating agent. While this facilitates LLM processing, it lacks deep cross-modal representation learning in the feature space. Establishing deep correlations between structural brain imaging and functional EEG signals within a latent space could potentially capture more intricate pathogenic mechanisms, further improving performance in complex neurological diagnoses. 2、Insufficient robustness analysis for missing modalities. Although the authors note that the MME dataset reflects clinical diversity (i. e. , only 94 of 306 patients have MRI, and 71 have EEG), the paper lacks a detailed analysis of how the specific agents and the central coordinator dynamically adjust their prompts or confidence thresholds when a core modality is missing. 3、Undefined conflict resolution mechanism. There is a potential for contradictory predictions between the generative and discriminative models. The consistency check performed by the coordinator currently lacks quantitative standards or a formalized arbitration logic. 4、Dataset bias and incomplete metrics. The MME dataset exhibits significant distribution bias (data imbalance). However, the paper only reports accuracy, omitting critical balanced metrics such as F1-score and recall. Without these, it is impossible to verify the model’s effectiveness on minority classes.
- Please rate the clarity and organization of this paper
Satisfactory
- Please comment on the reproducibility of the paper. Please be aware that providing code and data is a plus, but not a requirement for acceptance.
The submission has provided an anonymized link to the source code, dataset, or any other dependencies.
- Based on your review and your understanding of the MICCAI Scientific Code of Ethics, do you believe this submission may involve a potential ethics concern or violation?
N/A
- Optional: If you have any additional comments to share with the authors, please provide them here. Please also refer to our Reviewer’s guide on what makes a good review and pay specific attention to the different assessment criteria for the different paper categories: https://conferences.miccai.org/2026/en/REVIEWER-GUIDELINES.html
N/A
- Rate the paper on a scale of 1-6, 6 being the strongest (6-4: accept; 3-1: reject). Please use the entire range of the distribution. Spreading the score helps create a distribution for decision-making.
(3) Weak Reject — marginally below the acceptance threshold, but would not mind if accepted, dependent on rebuttal
- Please justify your recommendation. What were the major factors that led you to your overall score for this paper?
The limited method novelty and unclear writing leads to the overall score of this paper.
- Reviewer confidence
Confident but not absolutely certain (3)
- [Post rebuttal] After reading the authors’ rebuttal, please state your final opinion of the paper.
N/A
- [Post rebuttal] Please justify your final decision from above.
N/A
Review #2
- Please describe the contribution of the paper
This paper presents EPI-GUIDE, a new multi-agent system built around clinical guidelines to help manage epilepsy. It brings together two main parts: specialized models that handle specific tasks and give clear, quantitative results, and large language model agents that coordinate everything, making decisions based on international epilepsy guidelines. Together, they tackle a range of jobs-like figuring out seizure types, pinpointing where seizures start in the brain, recommending medications, and predicting how patients will do after surgery. Everything works as a unified system, drawing on different types of information to support decision-making for epilepsy care.
- Please list the major strengths of the paper: you should highlight a novel formulation, an original way to use data, demonstration of clinical feasibility, a novel application, a particularly strong evaluation, or anything else that is a strong aspect of this work. Please provide details, for instance, if a method is novel, explain what aspect is novel and why this is interesting.
++ combines the reliability of discriminative models with the flexibility of generative agents, addressing the instability and hallucination issues of pure LLMs ++ the orchestrating agent uses established international epilepsy guidelines ++ Results show significant accuracy improvements across all six tasks
- Please list the major weaknesses of the paper. Please provide details: for instance, if you state that a formulation, way of using data, demonstration of clinical feasibility, or application is not novel, then you must provide specific references to prior work.
- integrating multiple discriminative models, LLM agents and a central orchestrator likely requires substantial hardware resources, which could hinder deployment in low‑resource clinical settings.
- Please rate the clarity and organization of this paper
Satisfactory
- Please comment on the reproducibility of the paper. Please be aware that providing code and data is a plus, but not a requirement for acceptance.
The submission has provided an anonymized link to the source code, dataset, or any other dependencies.
- Based on your review and your understanding of the MICCAI Scientific Code of Ethics, do you believe this submission may involve a potential ethics concern or violation?
N/A
- Optional: If you have any additional comments to share with the authors, please provide them here. Please also refer to our Reviewer’s guide on what makes a good review and pay specific attention to the different assessment criteria for the different paper categories: https://conferences.miccai.org/2026/en/REVIEWER-GUIDELINES.html
N/A
- Rate the paper on a scale of 1-6, 6 being the strongest (6-4: accept; 3-1: reject). Please use the entire range of the distribution. Spreading the score helps create a distribution for decision-making.
(4) Weak Accept — marginally above the acceptance threshold, but would not mind if rejected, dependent on rebuttal
- Please justify your recommendation. What were the major factors that led you to your overall score for this paper?
++ combines the reliability of discriminative models with the flexibility of generative agents, addressing the instability and hallucination issues of pure LLMs ++ the orchestrating agent uses established international epilepsy guidelines ++ Results show significant accuracy improvements across all six tasks But - integrating multiple discriminative models, LLM agents and a central orchestrator likely requires substantial hardware resources, which could hinder deployment in low‑resource clinical settings.
- Reviewer confidence
Somewhat confident (2)
- [Post rebuttal] After reading the authors’ rebuttal, please state your final opinion of the paper.
N/A
- [Post rebuttal] Please justify your final decision from above.
N/A
Review #3
- Please describe the contribution of the paper
This paper proposes EPI-GUIDE, a hybrid multi-agent framework for holistic epilepsy management. The system integrates modality-specific discriminative models (ResNet-50, MedSigLIP, PubMedBERT, REVE) with generative LLM agents (MedGemma variants), coordinated by a RAG-grounded orchestrating agent (GPT-OSS-120b) that is anchored to international epilepsy clinical guidelines (ILAE, NICE).
- Please list the major strengths of the paper: you should highlight a novel formulation, an original way to use data, demonstration of clinical feasibility, a novel application, a particularly strong evaluation, or anything else that is a strong aspect of this work. Please provide details, for instance, if a method is novel, explain what aspect is novel and why this is interesting.
The framework addresses six epilepsy management tasks across two datasets — a curated multi-modal multi-task epilepsy (MME) cohort and a public HD-EEG dataset. Ablation studies confirm the contribution of both discriminative auxiliary guidance and RAG-based guideline grounding. Expert neurologist evaluation on 15 cases further validates clinical utility.
- Please list the major weaknesses of the paper. Please provide details: for instance, if you state that a formulation, way of using data, demonstration of clinical feasibility, or application is not novel, then you must provide specific references to prior work.
1.Section 2.2 states that the orchestrator issues FOLLOW-UP queries “to resolve discrepancies” when evidence is inconsistent, and may perform up to three multi-turn rounds. However, the termination condition for transitioning from FOLLOW-UP to COMPLETE is not formally specified beyond the qualitative description in Equation (4). Could the authors provide the explicit decision rule by which the orchestrator determines that sufficient concordance has been reached, and report statistics on how frequently each number of turns (1, 2, 3) was required across different tasks and datasets?
2.The ablation study in Table 3 evaluates four configurations by removing discriminative guidance and/or RAG independently. However, two important ablation dimensions are absent: first, the contribution of the multi-turn interaction mechanism itself (i.e., replacing iterative FOLLOW-UP queries with a single-turn orchestration); and second, the effect of the specific guideline corpus (e.g., replacing ILAE/NICE guidelines with a general medical knowledge base or no grounding). Without these ablations, it is difficult to attribute the 7.0-point gain from RAG specifically to epilepsy-specific guideline content rather than to the retrieval mechanism in general.
3.The HD-EEG public dataset comprises only 7 subjects and 61 stimulation sessions, which is an extremely small sample for evaluating a multi-agent framework. The standard deviations reported in Table 2 are correspondingly large (e.g., EZ localization: 64.1±5.2 for EPI-GUIDE vs. 60.8±14.1 for REVE), suggesting high variance across folds.
- Please rate the clarity and organization of this paper
Satisfactory
- Please comment on the reproducibility of the paper. Please be aware that providing code and data is a plus, but not a requirement for acceptance.
The submission does not mention open access to source code or data, but provides a clear and detailed description of the algorithm to ensure reproducibility.
- Based on your review and your understanding of the MICCAI Scientific Code of Ethics, do you believe this submission may involve a potential ethics concern or violation?
N/A
- Optional: If you have any additional comments to share with the authors, please provide them here. Please also refer to our Reviewer’s guide on what makes a good review and pay specific attention to the different assessment criteria for the different paper categories: https://conferences.miccai.org/2026/en/REVIEWER-GUIDELINES.html
N/A
- Rate the paper on a scale of 1-6, 6 being the strongest (6-4: accept; 3-1: reject). Please use the entire range of the distribution. Spreading the score helps create a distribution for decision-making.
(3) Weak Reject — marginally below the acceptance threshold, but would not mind if accepted, dependent on rebuttal
- Please justify your recommendation. What were the major factors that led you to your overall score for this paper?
While this paper tackles an important problem and presents some promising results, there are several key issues that need to be addressed before it can be considered in its current form.
- Reviewer confidence
Confident but not absolutely certain (3)
- [Post rebuttal] After reading the authors’ rebuttal, please state your final opinion of the paper.
N/A
- [Post rebuttal] Please justify your final decision from above.
N/A
Review #4
- Please describe the contribution of the paper
This paper proposes EPI-GUIDE, a clinical guideline-grounded hybrid agentic framework for holistic epilepsy management. The framework combines modality-specific discriminative models and modality-specific generative agents, converts discriminative outputs into textual auxiliary evidence, and then uses a central orchestrating agent grounded in international epilepsy guidelines to integrate multimodal evidence and make task-specific decisions. The paper evaluates the framework across two datasets and six epilepsy-related tasks, including epilepsy type classification, seizure type classification, epileptogenic zone localization, antiseizure medication response prediction, surgical outcome prediction, and stimulation-related tasks. The work also introduces a curated multi-modal, multi-task epilepsy benchmark intended for public release.
- Please list the major strengths of the paper: you should highlight a novel formulation, an original way to use data, demonstration of clinical feasibility, a novel application, a particularly strong evaluation, or anything else that is a strong aspect of this work. Please provide details, for instance, if a method is novel, explain what aspect is novel and why this is interesting.
1.The paper addresses a clinically important and genuinely multi-disciplinary problem. Epilepsy management is not a single-task prediction problem, and the manuscript correctly recognizes the need to integrate EEG, MRI, clinical data, and guideline-based reasoning. 2.The hybrid design is well motivated. The combination of discriminative models for robust modality-specific prediction and generative agents for coordination and explanation is sensible, especially given the known instability of purely generative multi-agent systems in medicine. 3.Guideline grounding is a meaningful contribution. Rather than relying on unconstrained LLM discussion, the framework explicitly uses epilepsy guidelines and textbook knowledge to structure the orchestrator’s decision pathway. 4.The paper evaluates the framework on multiple clinically relevant tasks rather than only one narrow benchmark. This broadens the practical relevance of the work and better reflects real-world epilepsy workflows. 5.The experimental results are promising. On the MME dataset, EPI-GUIDE improves over both strong discriminative baselines and generative baselines, and on the HD-EEG dataset it also outperforms the listed alternatives. 6.The ablation study is informative and supports the value of both discriminative auxiliary guidance and guideline-grounded retrieval. 7.The inclusion of qualitative expert review, although limited in scale, is a useful step toward clinical validation. 8.The manuscript is clearly organized and the framework diagrams are helpful.
- Please list the major weaknesses of the paper. Please provide details: for instance, if you state that a formulation, way of using data, demonstration of clinical feasibility, or application is not novel, then you must provide specific references to prior work.
1.The novelty should be positioned more carefully. Multi-agent and multi-modal medical reasoning frameworks have already been explored in prior work, including MDAgents [12], Agent Hospital [14], Pathfinder [6], and MedAgent-Pro [25]. In addition, epilepsy-specific foundation-model or LLM-based reasoning efforts such as epilepsy drug recommendation [22] and EZ localization from semiology using LLMs [28] have already started to appear. Therefore, the present work is better viewed as an important epilepsy-focused hybrid and guideline-grounded extension, rather than an entirely new starting point. 2.The claim of “holistic” epilepsy management should be interpreted with some caution. Although the framework spans multiple tasks, the actual data availability is still limited and incomplete: the curated cohort contains 306 patients, but MRI is available for only 94 and EEG for only 71, and several tasks have substantially fewer labeled cases. This makes the multimodal and multi-task setting clinically meaningful, but still relatively sparse in practice. 3.The fairness of the baseline comparison is not fully clear. EPI-GUIDE is a system-level framework combining multiple discriminative models, generative agents, guideline retrieval, and multi-turn orchestration, while several baselines are single-modality or single-model methods. The comparison is still useful, but it makes it difficult to isolate whether the gains come primarily from hybrid evidence integration, guideline grounding, or simply greater system complexity. 4.The paper would benefit from stronger detail on the benchmark construction and data split design. Because the MME dataset is heterogeneous and partially missing across tasks, more clarity is needed on how folds were generated, whether missing modalities create information imbalance across methods, and how stable the reported results are under this sparsity. 5.The expert evaluation is a positive addition but still limited in scale. Fifteen cases and 61 task-level judgments are encouraging as an initial qualitative validation, but this is not yet sufficient to strongly support broader claims about clinical reliability and utility. 6.Some claims about “more reliable and comprehensive decisions” are directionally plausible, but they currently rely mainly on task accuracy and a small-scale expert study. Additional error analysis, discordance analysis, or calibration-style evaluation would make these claims more convincing.
- Please rate the clarity and organization of this paper
Good
- Please comment on the reproducibility of the paper. Please be aware that providing code and data is a plus, but not a requirement for acceptance.
The authors claimed to release the source code and/or dataset upon acceptance of the submission.
- Based on your review and your understanding of the MICCAI Scientific Code of Ethics, do you believe this submission may involve a potential ethics concern or violation?
N/A
- Optional: If you have any additional comments to share with the authors, please provide them here. Please also refer to our Reviewer’s guide on what makes a good review and pay specific attention to the different assessment criteria for the different paper categories: https://conferences.miccai.org/2026/en/REVIEWER-GUIDELINES.html
I appreciate the authors for addressing epilepsy management as a genuinely multi-modal and multi-step clinical workflow rather than reducing it to a single prediction task. This is an important and underexplored perspective. I also think the paper makes a meaningful attempt to move beyond purely generative medical agents by introducing discriminative auxiliary evidence and explicit guideline grounding. The overall framework is thoughtfully designed, and I found the hybrid formulation clinically intuitive. In particular, the idea that modality-specific predictors should provide structured evidence, while a central agent integrates that evidence under guideline constraints, is sensible and relevant for real-world decision support. My main suggestions are aimed at strengthening the paper rather than questioning its overall direction. First, I encourage the authors to moderate the “first” claim and more explicitly position the work relative to existing multi-agent medical reasoning and epilepsy-specific AI systems. Second, the paper would benefit from a more detailed account of the MME cohort, including missing-modality patterns and how these affect the folds and task-specific comparisons. Third, I would welcome stronger analysis of what exactly the orchestrator contributes beyond strong modality-specific models, especially in discordant or incomplete-information cases. Finally, the expert evaluation is a good start, but expanding the qualitative/clinical assessment would substantially strengthen the claims of reliability and practical value. Overall, I found the paper promising, clinically relevant, and more mature than many purely agentic medical AI submissions.
- Rate the paper on a scale of 1-6, 6 being the strongest (6-4: accept; 3-1: reject). Please use the entire range of the distribution. Spreading the score helps create a distribution for decision-making.
(4) Weak Accept — marginally above the acceptance threshold, but would not mind if rejected, dependent on rebuttal
- Please justify your recommendation. What were the major factors that led you to your overall score for this paper?
My recommendation is based on the paper’s clear clinical motivation, coherent system design, and promising empirical performance, balanced against some limitations in novelty positioning and validation depth.
I think this work addresses an important gap in current medical AI for epilepsy. Rather than treating each task in isolation, the paper proposes a hybrid framework that integrates modality-specific discriminative evidence, generative interpretation, and explicit guideline-grounded orchestration. This is a meaningful direction, and the results across two datasets and multiple tasks are encouraging. The ablation study also supports the importance of both discriminative auxiliary evidence and guideline grounding.
At the same time, I think some claims should be framed more carefully. The novelty is partly incremental relative to prior multi-agent and multimodal medical reasoning work, the curated dataset is still relatively small and incomplete across modalities/tasks, and the expert evaluation is limited in scale. I would also have liked a clearer decomposition of what the orchestrating agent contributes beyond strong task-specific predictors.
Despite these limitations, I believe the paper makes a useful and timely contribution. It is clinically grounded, experimentally broader than many competing submissions, and points toward an important direction for hybrid agentic medical decision support. For these reasons, I place it slightly above the acceptance threshold.
- Reviewer confidence
Confident but not absolutely certain (3)
- [Post rebuttal] After reading the authors’ rebuttal, please state your final opinion of the paper.
Accept
- [Post rebuttal] Please justify your final decision from above.
After reading the authors’ rebuttal, I maintain my recommendation in favor of acceptance. The rebuttal addresses several of my main concerns in a meaningful way. In particular, the authors clarified that they will soften the novelty claim and position the work more appropriately as a hybrid, guideline-grounded extension for epilepsy care rather than as a wholly new paradigm. They also substantially improved the transparency of the orchestration mechanism by specifying the confidence-weighted concordance rule, the COMPLETE/FOLLOW-UP threshold, the three-tier arbitration logic, and the distribution of required follow-up rounds on the MME dataset. In addition, they provided useful missing-modality analyses (including T-only, T+M, T+E, M-only, and E-only settings), clarified how missing modalities are handled through prompt branching and weight renormalization, and added more detail on the 5-fold split strategy and the omitted weighted/macro F1 results. These clarifications strengthen my confidence in the paper. In particular, they make the hybrid system more interpretable at the decision level and reduce my earlier concern that some important implementation and evaluation details were underspecified. I also appreciate that the authors responded constructively by explicitly narrowing some of their claims, especially around novelty and the current scale of the expert reader study. That said, some limitations remain. The expert evaluation is still relatively small, the HD-EEG benchmark remains limited in size, and the deeper contribution of multi-turn orchestration appears concentrated in harder cases rather than yielding a large overall gain. I also still view the current fusion strategy as relatively shallow compared with more deeply integrated multimodal approaches. However, these are limitations rather than fatal flaws, and in my view they do not outweigh the paper’s strengths: clear clinical motivation, a coherent hybrid design, meaningful use of guideline grounding, and broad evaluation across multiple epilepsy management tasks. For these reasons, I support acceptance and keep the paper slightly above the acceptance threshold.
Author Feedback
Thank you for recognizing the importance of our work and your constructive feedback. If we have addressed your concerns, we kindly ask to reconsider your score.
Open-source: EPIGUIDE (code, prompts, configs) and MME, to our knowledge the first multi-modal multi-task epilepsy benchmark, are released at the anonymous link.
1.Novelty, reader study (R#4): Our novelty lies in the hybrid discriminative-generative coupling, guideline grounding via expert-curated ILAE documents, and multi-task epilepsy management. We will position this as a hybrid, guideline-grounded epilepsy care extension rather than an entirely new paradigm in the revision. We acknowledge the limited scale of our expert reader study, but the large gap (93.4% vs 54.1% task accuracy; 3.64 vs 2.64 Likert for EPIGUIDE vs LLM-only) suggest “promising preliminary results in assistive epilepsy management”. We will revise claims accordingly and outline larger scale studies, error analysis, and reasoning evaluation as future work.
2.Orchestrator conflict resolution (R#1,R#3,R#4): For each patient/task, the orchestrator compares the classifier’s top-1 prediction (with confidence) to modality agents’ top-1 labels, aggregating agreement into a confidence-weighted patient-level concordance score. If ≥0.7 (empirically selected threshold), the case is marked COMPLETE; otherwise, a FOLLOW-UP targets the most disagreed/lowest-confidence task (≤3 rounds; 44.4%|42.5%|13.1% cases required 1|2|3 rounds on MME). Final predictions from orchestrator apply a three-tier rule: trust the classifier if confidence ≥85%, defer to the generative model if <50%, else apply a confidence-weighted vote. On the 22–45% disagreement cases, the three-tier rule yields a mF1 of 65% vs mF1 of 27% for generative-only orchestration, demonstrating the value of hybrid approach.
3.Missing modality, orchestrator ablations (R#1,R#3,R#4): On all 306 patients, EPIGUIDE under reduced modalities (were omitted due to brevity) achieved T-only 80.1%, T+M 83.4%, T+E 82.6%; M-only (29.9% on the 94-MRIs) and E-only (50.6% on the 71 EEGs) confirm text as the anchor modality, with imaging adding complementary gains. The orchestrator handles missing modality via a “No-data” prompt branch, renormalised modality weights, and confidence-tier routing to the generative model. Replacing FOLLOW-UP with single-pass yields negligible overall gain (+0.1%), but +6.3% on cases needing ≥2 rounds, indicating benefits for harder cases. The +7.0% RAG gain decomposes into +3.0% generic retrieval of topic-matched Pubmed articles and +4.0% ILAE/NICE-specific content, with the epilepsy-specific gains concentrated on EZ localization and surgical outcome.
4.MME split, metrics, variance (R#4,R#1,R#3): On 306 patients (5 tasks, missing modalities), our 5-fold CV is stratified by epilepsy type and modality availability (has_mri × has_eeg), ensuring balanced folds with no patient overlap. We computed wF1, mF1, but omitted for brevity. EPI-GUIDE achieves 84–86 wF1|78–80 mF1 vs 78.0|71.3 (best ensemble) and 56.8|43.1 (MedGemma-27B zero-shot), to be added to Table 1.The 6.6 wF1–mF1 gap is driven by low recall of <45% on minority classes: Multifocal EZ and On-treatment AED response. On HD-EEG, variance is higher due to the smaller cohort, though EPIGUIDE still shows lower variance than REVE (Table 2).
5.Simple fusion (R#1): Our choice deliberately mirrors real epilepsy MDT meetings where specialists interpret evidence independently before joint deliberation, and also to isolate our core novelty (see point 1). Table 3 confirms gains stem from discriminative evidence (+22.9) and guidelines (+7.0), not fusion depth. Missing modalities in the MME (MRI: 94/306, EEG: 71/306) complicate latent fusion, but we agree this is a promising future direction.
6.Compute (R#2): 8×A100 setup is for running GPT-OSS-120B locally; discriminative models are lightweight. Our modular design allows swapping in more efficient models, which we will note in the revision.
Meta-Review
Meta-review #1
- Your recommendation
Invite for Rebuttal
- Please justify your decision. In case you deviate from the reviewers’ recommendations, explain in detail the reasons why. In case of an invitation for rebuttal, clarify which points are important to address in the rebuttal.
This paper proposes EPI-GUIDE, a guideline-grounded hybrid multi-agent framework for holistic epilepsy management, combining discriminative and generative agents with a central orchestrator. Reviewers recognize the clinical relevance, coherent design, and promising performance across multiple datasets and tasks.
The authors should focus on clarifying and addressing the following points: position the novelty more carefully relative to prior multi-agent and multimodal epilepsy AI systems; provide more details on the MME dataset, including missing-modality patterns, data splits, and their effect on task-specific comparisons; clarify the contribution of the orchestrator beyond strong modality-specific predictors, particularly in discordant or incomplete-information cases; expand the qualitative and clinical expert evaluation to strengthen claims of reliability and practical value; and frame claims about “holistic” management and novelty more cautiously given dataset limitations.
- After you have reviewed the rebuttal and updated reviews, please provide your recommendation based on all reviews and the authors’ rebuttal.
Reject
- Please justify your recommendation.
The paper has clear clinical motivation and promising empirical results, but the reviews remain mixed and mainly weak. Concerns about limited methodological novelty, unclear writing, deployment complexity, and insufficient validation depth were not convincingly overcome. On balance, the work seems promising but not yet strong enough for acceptance.
Meta-review #2
- After you have reviewed the rebuttal and updated reviews, please provide your recommendation based on all reviews and the authors’ rebuttal.
Accept
- Please justify your recommendation.
The review process has navigated a set of careful reviews that were tied between ‘weak reject’ and ‘weak accept’. But after consideration of the rebuttal, there has been a slight swing in the positive direction. Authors are encouraged to follow the careful reviews and constructive commentary.
Meta-review #3
- After you have reviewed the rebuttal and updated reviews, please provide your recommendation based on all reviews and the authors’ rebuttal.
Accept
- Please justify your recommendation.
In the rebuttal the authors addressed previously underspecified points such as specifying the exact novelty.
